Latest filing published 28 May 2025 for Maravai Lifesciences Holdings, INC., €1,307.
Filing timeline
BuySaleInsider track record
Closed purchases
Not enough history yet: 1 closed purchase, at least 2 are needed.
Purchases by company
Since each purchase
- +32.7%Entry US$5.50 · Close at T+365 US$7.30
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Kevin Herde: trading record in brief
Filings by Kevin Herde span 2 companies, the busiest being Maravai Lifesciences Holdings, Inc. and Sorrento Therapeutics, Inc. The record holds 21 filings, for trades running from 3 February 2017 to 15 May 2025.
Every open-market trade on record is a purchase: 1 purchase worth €14k, and no sale. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Other entries cover 20 share grants.
The record was last updated on 28 May 2025 with a share grant (€1,307) in Maravai Lifesciences Holdings, Inc. The last insider purchase was made public on 3 February 2017, 3,566 days ago. Filings reach the SEC (Form 4) feed a median of 3 days after the trade. US insiders must file a Form 4 within two business days of a trade. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Kevin Herde
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 876 shares@ US$1.670.3% of flowClass A Common StockSEC:0001823239-25-000069:0
- 8,648 shares@ US$2.645.1% of flowClass A Common StockSEC:0001823239-25-000044:0
- 394,478 sharesClass A Common StockSEC:0001823239-25-000056:0
- 2,326 shares@ US$4.102.2% of flowClass A Common StockSEC:0001823239-25-000022:0
- 46,344 shares@ US$4.5649.7% of flowClass A Common StockSEC:0001823239-25-000015:0
- 1,906 shares@ US$5.702.4% of flowClass A Common StockSEC:0001823239-24-000117:0
- 1,780 shares@ US$5.702.3% of flowClass A Common StockSEC:0001823239-24-000055:0
- 8,624 shares@ US$7.7014.8% of flowClass A Common StockSEC:0001823239-24-000036:0
- 2,664 shares@ US$5.483.3% of flowClass A Common StockSEC:0001823239-24-000025:0
- 250,277 sharesClass A Common StockSEC:0001823239-24-000010:0
- 1,861 shares@ US$5.832.5% of flowClass A Common StockSEC:0001823239-23-000096:0
- 874 shares@ US$11.722.3% of flowClass A Common StockSEC:0001823239-23-000068:0
- 72,507 sharesClass A Common StockSEC:0001823239-23-000028:0
- 2,611 shares@ US$15.239.0% of flowClass A Common StockSEC:0001823239-23-000007:0
- 478 shares@ US$14.111.6% of flowClass A Common StockSEC:0001823239-22-000063:0
- 427 shares@ US$22.952.3% of flowClass A Common StockSEC:0001823239-22-000026:0
- 19,500 sharesClass A Common StockSEC:0000899243-22-003418:2
- 392 shares@ US$22.951.8% of flowClass A Common StockSEC:0000899243-22-003418:1
- 497 shares@ US$22.952.3% of flowClass A Common StockSEC:0000899243-22-003418:0
- 3,000 shares@ US$5.15100.0% of flowCommon StockSEC:0000899243-17-002785:0Canonical exit: 4 May 2017 (T+90)
20 of 20 declarations
